Recent updates
England and Wales (April 2008)
updated 1 May
Renagel container status (PJ 2007;278:339, 24 March 2007)
The Department of Health has confirmed the removal of Renagel (sevelamer; Genzyme)
tablets 800mg from the Drug Tariff’s special container list from March. |
Category M
The reimbursement prices for 40 Category M products will change in November
based on the receipt of corrected information from manufacturers by
the Department of Health.
A list
of the updated prices (November 2006)
Category M price changes have been announced for prescriptions dispensed
in October to December 2006. There are no additions or deletions to
Category M in this quarter (September 2006).
See The Electronic Drug Tariff
|
The Department of Health and the National Assembly
of Wales (from October 2000 onwards) have agreed to allow “No
cheaper stock obtainable” (NCSO) endorsements for the following
preparations for the relevant month's prescriptions
more
The Scottish Pharmaceutical General Council has announced
that endorsements will be allowed for the relevant month for the following
items
more
Selected List Scheme
February 2005 amendments |
September 2004 Drug Tariff amendment (Pharmaceutical
Journal, 273;415)
The Prescription Pricing Authority says that the price increases
for B.Braun Medical’s Askina Biofilm transparent dressings
and to some of their Part IXC stoma appliances do not appear in the
paper edition of the September Drug
Tariff but are correctly listed in the electronic
version. These products will be reimbursed at the prices in the electronic
version.
|
dm&d naming convention (Pharmaceutical
Journal, 272;503)
The drugs listed in part VIII of the Drug Tariff will reflect the naming convention
used in the NHS
dictionary of medicines and devices (PJ, 10 April, p435). Full details
will be given in the preface of the May issue.
|
|
